EUVIMEDScopri EUVIMED
Video/Audio

Dihydrotanshinone I in Paired Vemurafenib-Sensitive and Resistant A375 Melanoma Cells

Xiaotang Jiang, Xiaohua Yang, Xiaoqing Wang, Cong Chang

Journal of Visualized Experiments · 2026-11-05 · (237)

DOI: 10.3791/74730 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, published online on 2026-11-05. Written by Xiaotang Jiang and 3 co-authors. Institution: Aviation General Hospital. Major MEDLINE topics: Melanoma, Sulfonamides, Indoles, Phenanthrenes.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Acquired resistance limits the response to vemurafenib in melanoma. This study investigated dihydrotanshinone I (DHT) in parental A375 cells and a vemurafenib-resistant derivative (A375R). An exploratory computational workflow combined target prediction, survival associations, tumor-versus-normal expression comparisons, dependency screening, least absolute shrinkage and selection operator (LASSO) Cox regression, and random survival forests. Heat shock protein 90 alpha family class A member 1 (HSP90AA1) and signal transducer and activator of transcription 3 (STAT3) were prioritized for cellular testing. Cellular thermal shift assays showed DHT-associated thermal stabilization, and combined small interfering RNA depletion produced greater phenotypic effects than single-target depletion. Eight drug combinations yielded Chou-Talalay combination indices of 0.520-0.940 in A375R cells. Transcriptional changes and lipid-peroxidation readouts were consistent with altered resistance-associated and oxidative-stress programs. Together, these findings support further investigation of HSP90AA1 and STAT3 in the response of resistant melanoma cells to DHT.

Subjects

MeSH terms (MEDLINE)

MelanomaSulfonamidesIndolesPhenanthrenesAntineoplastic AgentsHumansVemurafenibDrug Resistance, NeoplasmCell Line, TumorHSP90 Heat-Shock ProteinsSTAT3 Transcription FactorFuransQuinones

Substances

VemurafenibHSP90 Heat-Shock ProteinsSTAT3 Transcription FactorSulfonamidesdihydrotanshinone IIndolesPhenanthrenesAntineoplastic AgentsSTAT3 protein, humanFurans

Authors and institutions

  • Aviation General Hospital.
  • Huantai People's Hospital.
  • Qilu Medical University; m13853303789@163.com.
  • Qilu Medical University; 13475549111@163.com.

Cite

APA

Jiang, X., Yang, X., Wang, X., & Chang, C. (2026). Dihydrotanshinone I in Paired Vemurafenib-Sensitive and Resistant A375 Melanoma Cells. Journal of Visualized Experiments. https://doi.org/10.3791/74730

Vancouver

Jiang X, Yang X, Wang X, Chang C. Dihydrotanshinone I in Paired Vemurafenib-Sensitive and Resistant A375 Melanoma Cells. Journal of Visualized Experiments. 2026. doi:10.3791/74730

BibTeX
@article{Jiang2026,
  author = {Jiang, Xiaotang and Yang, Xiaohua and Wang, Xiaoqing and Chang, Cong},
  title = {Dihydrotanshinone I in Paired Vemurafenib-Sensitive and Resistant A375 Melanoma Cells},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  number = {237},
  doi = {10.3791/74730}
}
Start for free →